Barclays’s Semler Scientific SMLR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-82,363
| Closed | -$1.26M | – | 5399 |
|
|
2025
Q4 | $1.26M | Buy |
82,363
+5,688
| +7% | +$129K | ﹤0.01% | 3279 |
|
|
2025
Q3 | $2.3M | Buy |
76,675
+349
| +0.5% | +$12K | ﹤0.01% | 2788 |
|
|
2025
Q2 | $2.96M | Buy |
76,326
+15,780
| +26% | +$562K | ﹤0.01% | 2547 |
|
|
2025
Q1 | $2.19M | Buy |
60,546
+52,995
| +702% | +$2.48M | ﹤0.01% | 2567 |
|
|
2024
Q4 | $408K | Sell |
7,551
-113
| -1% | -$5.19K | ﹤0.01% | 3952 |
|
|
2024
Q3 | $180K | Sell |
7,664
-3,626
| -32% | -$104K | ﹤0.01% | 4351 |
|
|
2024
Q2 | $388K | Buy |
11,290
+7,977
| +241% | +$230K | ﹤0.01% | 3200 |
|
|
2024
Q1 | $96.8K | Sell |
3,313
-3,227
| -49% | -$135K | ﹤0.01% | 4445 |
|
|
2023
Q4 | $290K | Buy |
6,540
+5,416
| +482% | +$195K | ﹤0.01% | 4233 |
|
|
2023
Q3 | $28.5K | Buy |
1,124
+125
| +13% | +$3.25K | ﹤0.01% | 4076 |
|
|
2023
Q2 | $26.2K | Sell |
999
-10,064
| -91% | -$265K | ﹤0.01% | 4080 |
|
|
2023
Q1 | $296K | Buy |
11,063
+8,205
| +287% | +$230K | ﹤0.01% | 3584 |
|
|
2022
Q4 | $94.3K | Buy |
2,858
+2,556
| +846% | +$88.7K | ﹤0.01% | 4260 |
|
|
2022
Q3 | $11K | Buy |
+302
| New | +$11.4K | ﹤0.01% | 4273 |
|
Barclays's SMLR Position: Q1 2026 in Review
Barclays sold out of Semler Scientific (SMLR) in Q1 2026, closing a stake of 82,363 shares — an estimated $1.26M sold.
Barclays first reported a position in SMLR in Q3 2022 and held it in 14 quarters. The position peaked at $2.96M in Q2 2025. 0 funds tracked by Wall St. Rank hold SMLR as of Q1 2026.
- Barclays reported no remaining Semler Scientific position as of Q1 2026 after selling out during the quarter.
- Barclays sold 82,363 Semler Scientific shares in Q1 2026, an estimated $1.26M.
- Barclays first reported a position in Semler Scientific in Q3 2022 and held it in 14 quarters.
- Barclays's Semler Scientific position peaked at $2.96M in Q2 2025.
- 0 funds tracked by Wall St. Rank held Semler Scientific as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.